Abstract
Teladorsagia circumcincta is a common species of parasitic worm that infects sheep in the UK.
The parasite causes an estimated £84 million per annum in production loss to UK farmers, through loss of appetite and growth impairment in young stock. Animals are treated regularly with anthelmintic (drench) throughout spring and summer to reduce their worm burden. However, the overuse of these drugs has led to the evolution of drug-resistant parasites which are extremely difficult to kill. This has led to research into other ways to manage the infection, with the aim to limit the development of drug resistance whilst maintaining flock health.
Sheep naturally acquire resistant immunity to the worms with repeated exposure to small numbers of the parasite. This immunity is also heritable, so lambs can be bred to naturally develop resistance to the parasite. The aims of this project were; 1) understand how sheep respond to worm infection, 2) understand and identify genes associated with the response and 3) identify variation within those genes which may contribute to resistance.
A number of immune response genes were sequenced within this project which led to the identification of several mutations within these genes. Quantifying the expression levels of the genes in resistant and susceptible lambs illustrated associations between the genes and the development of resistance. Therefore, the genes investigated in this project have the potential to aid genetic selection of worm-resistant sheep in the future.
Introduction
One of the most common gastro-intestinal parasites of sheep in the UK is the nematode Teladorsagia circumcincta, which infects the sheep's fourth stomach (the abomasum) (Dunn, 1969) . Young lambs are highly susceptible and become infected soon after weaning. In time, lambs develop an immune response against the worms (Stear et al., 1999) . This can either lead to clearance of the infection, termed resistance measured by reduced faecal egg count (FEC), reduced adult worm count (AWC), increased anti-parasite antibody (IgA) production and/or increased body weight (BW); or susceptibility, measured by high FEC, high AWC, low IgA and low BW (Beraldi et al., 2008) .
The production of protective antibodies is regulated by the differential polarization of T cells, and studies in mice have indicated the critical role of T helper type 2 (Th2) cells in the control of worm infection and the development of resistance (Allen and Maizels, 2011) . Inflammatory responses linked with the activation of Th1 and Th17 cells lead to tissue damage and exacerbated disease, resulting in the susceptibility traits (Ahern et al., 2008) .
The development of polarized T helper cell subsets is under the control of cytokine receptors (which bind to signalling (cytokine) molecules) and transcription factors (which are activated by cytokine receptor signalling and switch on other genes, initiating downstream pathways) (Murphy and Weaver, 2016) .
Th2 cells express the receptor for the cytokine interleukin-25 (IL25); the receptor is made up of two subunits -IL17RA and IL17RB. Signalling through this receptor activates the transcription factor GATA3 (Murphy and Reiner, 2002) . Th17 cells express the IL23 receptor, made up of the IL23R and IL12RB1 subunits. Signalling through this receptor activate two transcription factors: RORC2 and RORA (Gaffen, 2009 ). Th1 cells express the receptor for IL12, which is made up of the IL12RB1 and IL12RB2 subunits. When IL12 binds to its receptor the transcription factor TBX21 is activated (Murphy and Weaver, 2016) .
Alternative splicing is a common mechanism by which multiple variants of the same gene are created (Breitbart et al., 1987) . This can introduce non-productive mutations (where the variant is useless and immediately broken down by the cell) as well as beneficial mutations (such as different expression of different variants in different tissues).
The hypothesis of this project was that genes involved in differential T helper cell activation could be key to the development of resistance and susceptibility. Furthermore, it was believed that mutations within these cytokine receptor and transcription factor genes may cause inhibition of certain responses (e.g. Th17) leading to activation of the competitive response (e.g. Th2).
To investigate this hypothesis, experimentally infected Blackface ewe lambs were utilised which had been bred to have a range of susceptibilities to T. circumcincta (Beraldi et al., 2008) . The transcription factors (GATA3, RORA, RORC2 and TBX21) were sequenced in the abomasal lymph node (ALN; the draining lymph node and site of immune response initiation in this infection) and splice variants were identified. Assays were designed to quantify the expression of these genes and variants in the ALN and the abomasal mucosa (AM; the site of infection). The cytokine receptor subunits (IL17RA, IL17RB, IL23R and IL12RB1) were sequenced by Nicol et al. (2016) .
Quantification assays were also designed by Nicol et al. (2016) ; these were then optimised for use in the current study. Genes that were significantly differentially expressed between the most resistant and susceptible lambs were then analysed further for correlations with resistant traits (FEC, AWC, IgA and BW), indicating genes with potential as selection markers of resistant lambs.
These results were published by Wilkie et al. (2016a) and Wilkie et al. (2016b) .
Materials and methods

Animals and experimental design
Female Blackface lambs were ~13 weeks old were housed in worm-free conditions; 45 lambs were infected with ~2300 infective L3 T. circumcincta larvae three times a week for 12 weeks, and 10
were sham-infected controls. At post mortem the AWC ranged from 0 to 11,300 and FEC from 0 -950 eggs per g (Table 1 ) and the animals were ranked (1 -45) according to their infection level. All details of animals and animal husbandry, infection protocols, phenotypes and population genetic analyses have been previously described (Beraldi et al., 2008 
Sample collection and RNA isolation
Abomasal lymph node (ALN) and mucosa (AM) was removed immediately post mortem and stored at -80˚C in RNAlater (Ambion, UK). Total RNA was isolated from ~ 20mg tissue using the Ribopure Kit (Ambion) according to the manufacturers' instructions, and genomic DNA was removed by on-column PureLink® DNase I treatment (Ambion). RNA quantity, quality and integrity was assessed by a NanoDrop ND-1000 spectrophotometer and Agilent 2200 TapeStation system; all samples had an RNA Integrity Number of >7.5.
Cloning and sequencing of transcription factors
cDNA was synthesised from 1 μg RNA using SuperScript™ II RT with RNaseOUT (Invitrogen, UK) and oligo-dT (15) were sequenced using T7 and SP6 primers, with BigDye1Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, UK). The GeneRacerTM Kit for full-length, RNA ligase-mediated rapid amplification of 5' and 3' cDNA ends (Invitrogen) was used to sequence the 5' and 3' untranslated region (UTR) of the transcription factors. Primers and nested primers were designed (Wilkie et al., 2016a ) and the protocol was followed as detailed by the manufacturer, using SuperScript TM III protocol for reverse transcription reaction and Platinum (R) Taq DNA Polymerase High Fidelity protocol for the amplification of the final product, which were cloned as described above.
RT-qPCR quantification of transcript variants
cDNA was synthesised from 1.0 μg RNA using SuperScript™ II RT with RNaseOUT (Invitrogen, UK) and oligo-dT(15) primer (Promega, UK) in 20 μl final volume. Quantification primers for the transcription factor and cytokine receptor variants have been published by Wilkie et al. (2016a) and Nicol et al. (2016) . Primers were designed to overlap exon/exon boundaries; all amplicons were sequenced to ensure specificity. Each reaction contained 7.5 μl FastStart Universal SYBR Green Master (Rox) 2x concentrated master mix (Roche), 2 μl template cDNA (diluted 1/10), 0.25 -1.0 μl of each primer at 10 mM and nuclease-free water to a final volume of 15 μl. Reactions were prepared using a CAS-1200™ robot and performed on a Rotor-Gene Q (Qiagen). Amplification was followed by dissociation curve analysis. PCR optimization was performed on cDNA from a pool of samples. Not all variants could be quantified in the AM; the signals for GATA3v1, RORAv2, v3, v4 and v5; and IL23Rv1, v2, v3, v4 and v5; IL12RB1v1, v2 and v4;  and IL17RBv1 were too low for accurate quantification as they were detected only after > 30 cycles PCR, outside the linear part of the standard curve.
Relative expression levels were measured in duplicate from two separate RT reactions for each of the nine most resistant and the nine most susceptible lambs, with duplicate no-template controls included in all runs. Optimized RT-qPCR assays had an efficiency >95% and R 2 value of >0.98.
Absolute copy numbers were also calculated from duplicate samples from two separate RT reactions for all lambs.
Relative transcript levels were calculated in GenEx 5 (MultiD Analyses AB, Sweden) using the comparative 2-(ΔΔ Cq) method and normalized to the geometric mean of GAPDH and SDHA; fold changes were calculated from ΔCq values using GenEx. To calculate copy number in all 45 infected and the 10 uninfected sheep, a standard curve of linearized plasmid was used with a dynamic range of at least five orders of magnitude. For each point on the standard curve, copy numbers were calculated from Cq values:
M= plasmid size x 660g/mol per bp.
The expression levels were normalized by dividing the copy number derived from the standard curve, by the calculated normalization factor (Vandesompele et al., 2002) for each sample, using the geometric mean of GAPDH and SDHA. RT replicates were averaged per animal and multiplied by the dilution factor (x100) to calculate the copy number per μg of total RNA.
Statistical analysis
Relative transcript levels were analysed in GenEx using an unpaired, 2-tailed t-test to determine the difference between groups. Graph Pad Prism 6.07 for Windows (Graph Pad Software, USA)
was used for statistical analysis of the copy number expression data. The data were grouped into resistant, intermediate, susceptible (n =15 per group) and uninfected control (n =10). One-way ANOVA was performed to determine overall significance and Tukey's multiple comparisons test within ANOVA was used to determine significance between groups. Correlations between transcript levels and quantitative phenotypes were analysed with 2-tailed Spearman's correlation coefficient (rs); P-values ≤ 0.05 were considered statistically significant. 
Results
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RT-qPCR quantification of transcription factor expression (Wilkie et al., 2016a and 2016b)
Relative RT-qPCR assays were developed for TBX21, for the two variants of GATA3 and RORC2
and for five variants of RORA. These were used to compare the nine most resistant (R) and the nine most susceptible (S) lambs (Table 1 ). The resistant group (rank 1-9) had no detectable AWC or FEC, mean body weight (BW) of 37 kg and high IgA antibody levels (mean 0.76 relative units).
The susceptible lambs (rank 37-45) were those with the highest AWC (mean 6078, maximum 11300), high FEC (mean 350, maximum 950), low BW (mean 23.7 kg) and low IgA (mean 0.22 units). Table 2 shows the relative expression (fold change) of each transcription factor and variant between the resistant and susceptible groups and shows that all but RORAv5 were equally expressed in the ALN of both groups. RORAv5 was 1.57 fold higher in the resistant animals but p = 0.08. RORAv3 could not be quantified because expression levels were too low for accurate measurement.
In the abomasal mucosa, GATA3 was significantly increased 2.06 fold (p = 0.0002) in the resistant animals and RORC2v1 (-1.30 fold, p = 0.03) was significantly decreased in the resistant animals compared to susceptible lambs (Table 2 ). Full length RORC2 was also significantly decreased in the resistant group (-1.41 fold, p = 0.01). TBX21 and RORAv1 were not significantly differentiallyexpressed. Bold: significant P values.
Correlation of transcription factor levels in ALN and quantitative phenotypes (Wilkie et al., 2016a)
Absolute quantitative analysis was performed on RORAv5 as it was the only transcription factor variant that showed evidence of differential expression between the R and S groups in the ALN;
RORAv2 was also quantified as the control RORA variant. Table 3 shows the relative expression (resistant vs. susceptible, fold change and P-value) of each quantifiable variant in the ALN and AM. In the ALN, IL17RB was significantly increased 1.62 fold (p = 0.03) in the resistant animals and IL23R approached significance (-2.76 fold, p = 0.08) compared to susceptible lambs. In the AM, only IL17RBv2 was significantly differentially expressed (2.10 fold, p = 0.01). All other subunit genes were not significantly differentially-expressed or not quantifiable. IL12RB1v4 -1.04 0.89 * * Signals obtained after 30 PCR cycles were too low to quantify. IL23R variants 1-5 and IL12RB1 variants 1-2 were too low to quantify in either tissue, for which a positive control confirmed the assays were optimised. Bold: significant P values.
ANOVA confirmed the expression of
RT-qPCR quantification of cytokine receptor expression (Wilkie et al.,
2016b)
Correlation of cytokine receptor levels in AM and quantitative phenotypes (Wilkie et al., 2016b)
In the abomasal mucosa, IL17RB was expressed in equal levels in all infected groups (resistant 23207 ± 12487, intermediate 17653 ± 7217, susceptible 14338 ± 9907), but was significantly lower in the control group (1234 ± 538), compared to resistant (p value < 0.0001), intermediate (p value < 0.0001) and susceptible (p value < 0.001) groups ( Figure 8A ).
Mean levels of IL17RBv2 were not significantly different between any group (resistant 1182 ± 826, intermediate 987 ± 579, susceptible 652 ± 544, control 1006 ± 625; Figure 8B ), p value 0.18.
The correlation analysis found a significant negative correlation between IL17RB and AWC (rs -0.37, p value 0.01) and a significant positive correlation with BW (rs 0.40, p value 0.006; Figure 9 ).
There was no significant correlation between IL17RB and FEC (rs -0.26, p value 0.08) or IgA (rs 0.26, p value 0.09). 
Spearman rank correlation analysis found a significant negative correlation between
Discussion
Previous studies on the immunological basis of resistance to T. circumcincta using this model have highlighted the role of Th2 cells in resistance and Th1/Th17 cell activation in susceptibility (Pemberton et al., 2011; Gossner et al., 2012) . This study represents the first systematic attempt to assess the role of the four major immune system transcription factors in an ovine infectious disease context.
In this study two transcript variants of GATA3 were detected, the DNA-binding domains of which share 100% peptide sequence identity with the DNA-binding domains of known human transcript variants. It is therefore predicted that the ovine transcripts will have similarly located functional domains. Both the human and ovine truncated variant have amino acid E260 deletion, however, there are no known functional effects of this mutation in humans and E260 is situated outside of any functional domains (Gaynor et al., 2009) . Within the abomasal lymph node, there was no significant difference between the resistant and susceptible groups in GATA3 or GATA3v1
expression. This result therefore suggests that at this late time point in chronic infection, there are similar levels of Th2 cells in the ALN of both resistant and susceptible lambs (Wilkie et al., 2016a) .
Within the abomasal mucosa, GATA3v1 levels were not detectable, however, GATA3 was significantly increased 2.10 fold in the resistant compared to susceptible lambs (Table 2 ). This is the first indication of a difference in expression of the shorter variant compared to the wild type gene, which potentially indicates a functional effect of the variant, although the mechanism of action is not clear. Correlation analysis in the mucosa found significant negative correlations between GATA3 and AWC, and significant positive correlations with BW and IgA (Wilkie et al., 2016b) . Therefore, not only is this gene increased in resistant lambs, it is also associated with the phenotypes of resistance. This is evidence of a robust association between GATA3 expression and the maintenance of resistance in chronic worm infection.
There were no splice variants of sheep TBX21 identified (Wilkie et al., 2016a) . TBX21 has been unambiguously sequenced in relatively few species, including humans, cattle and mice, and in all these species only a single gene has been characterized. Despite being detectable in the ALN and AM, there was no significant difference in TBX21 expression between the resistant and susceptible lambs. It is concluded that Th1 cells are not increased in the susceptible lambs relative to the resistant lambs at this time point. However, it is possible Th1 cells play a role in the early induction of the inflammatory response to nematodes, but this can not be investigated in the current model.
The two ovine RORC2 variants identified are homologous to human RORC2. The truncated protein predicted to be encoded by RORC2v1 has a 12 amino acid deletion in the predicted ligand-binding domain (Wilkie et al., 2016a) . There is a known variant of human RORC2 in which exons 5 -8
(within the hinge region of the ligand-binding domain) are deleted, causing suppression of IL17 production (Rauen et al., 2012) . It was therefore hypothesised that the ovine variant might also affect the function of Th17 cells and may be associated with resistance rather than susceptibility.
However, there was no significant difference between RORC2 and RORC2v1 in the resistant and susceptible groups in the ALN (Wilkie et al., 2016a) . This indicates there is little difference between the levels of Th17 cell activation in the ALN of resistant and susceptible lambs in late-stage chronic worm infection. In the abomasal mucosa, both RORC2 and RORC2v1 were significantly increased in the susceptible lambs relative to the resistant lambs, thereby indicating the ovine variant does not appear to have altered function (Wilkie et al., 2016b) unlike the human variant.
The identification of five variants of RORA within the ovine lymph node (Wilkie et al., 2016a) highlights the hitherto unexplored polymorphic capability of RORA within the immune system. The variants differ in their 5' UTR sequence and translational start site, particularly in their A/B domain sequence which is required for nuclear localisation (Aschrafi et al., 2006) . Data using mouse models of gastrointestinal nematode infections have shown that components of the excretory-secretory products of infecting helminths can suppress the immune response and can activate regulatory cells to enhance the suppression (Grainger et al., 2010) . These factors can lead to the inhibition of Th1 and the promotion of Th2 development. It is possible that some of the variation in the expression of the T cell genes in this study have been influenced by parasite secretions, for example RORC2v1 expression which was significantly lower in infected lambs compared to uninfected lambs (Figure 7) . T. circumcincta secreted products have also been shown to promote Foxp3-expression (a regulatory cell marker) in vitro (McNeilly et al., 2013) .
This study investigated the abomasal lymph node and mucosal expression of variants of the transcription factors and cytokine receptors associated with differential T cell activation.
Measurements of expression of each variant, in selected lambs with well-defined phenotypes of resistance to the abomasal parasite T. circumcincta, identified RORAv5, GATA3 and IL17RB levels were positively correlated with resistance and negatively correlated with susceptibility. This indicates that Th2-polarized T cells may play an important role in the maintenance of resistance and suggests these genes could be useful markers of worm-resistant sheep in the future.
Industry messages
The overall goal of this project was to identify candidate genes associated with resistance that could be used as selection markers for future breeding programmes. Using an experimentallyinfected Blackface lamb model, genes with characterised immune response functions in mice were investigated in sheep. This confirmed that these genes have robust associations with disease outcome in worm-infected lambs.
Current genetic techniques (such as SNP chips) use predominantly predicted mutations from cattle to interrogate the ovine genome for disease-associated genes. The genes, and mutations with them, discovered in this project, are real ovine mutations and represent novel markers that could be used for the genetic selection of worm-resistant sheep in the future.
